Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Ropivacaine 0.5 Percentage In Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries: A Randomised Clinical Trial

Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Ropivacaine 0.5 Percentage In Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries: A Randomised Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081248

Enrollment

Registered

2025-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S424- Fracture of lower end of humerus Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: 0.5 percentage Ropivacaine and Dexamethasone: Study participants will be randomized into two groups. Intervention group receiving 0.5% ropivacaine with dexamethasone as adjuvant in ultr

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group 18 to 60 years. 2. Patients of American Society of Anaesthesiologists (ASA) physical status grade I or II.

Exclusion criteria

Exclusion criteria: 1. Patients with hypertension, diabetes mellitus, autonomic neuropathy, peripheral nerve injury 2. Pregnancy or lactation. 3. Patients on anticoagulants or bleeding disorders. 4. Patients with hypersensitivy to amide group of local anaesthetic agents and dexmedetomidine. 5. Uncooperative/unwilling patients. 6. Local site infection.

Design outcomes

Primary

Measure	Time frame
Onset and duration of sensory and motor block (using HOLLMEN SCALE) using 0.5% Ropivacaine and dexmedetomidine as adjuvantTimepoint: Baseline and time when patient complains of pain and can start moving his limbs	—

Secondary

Measure	Time frame
Onset & duration of sensory & motor block (using HOLLMEN SCALE) using 0.5% ropivacaine & dexamethasone as adjuvantTimepoint: Baseline & time taken for patient to feel pain & move limbs	—

Countries

India

Contacts

Public ContactL Pradipkumar Singh

Regional institute of medical sciences, Imphal West, Manipur

drlaithangba@gmail.com7005238251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026